A case of malignant melanoma that developed multiple metastases after switching from interferon-beta to pegylated interferon-alpha-2b as adjuvant therapy

Eur J Dermatol. 2018 Feb 1;28(1):115-116. doi: 10.1684/ejd.2017.3169.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Brain Neoplasms / secondary
  • Chemotherapy, Adjuvant
  • Duodenal Neoplasms / secondary
  • Fatal Outcome
  • Humans
  • Interferon alpha-2 / therapeutic use*
  • Interferon-alpha / therapeutic use*
  • Interferon-beta / therapeutic use*
  • Liver Neoplasms / secondary
  • Male
  • Melanoma / drug therapy
  • Melanoma / pathology
  • Melanoma / secondary*
  • Melanoma, Cutaneous Malignant
  • Middle Aged
  • Polyethylene Glycols / therapeutic use*
  • Recombinant Proteins / therapeutic use
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology*

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Interferon-beta
  • peginterferon alfa-2b